PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
02-Jun-2020 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Akebia Therapeutics
02-Jun-2020 LaunchPad Medical Wins a Coveted $1.8 Million Michigan-Pittsburgh-Wyss Regenerative Medicine Center Grant LaunchPad Medical, Inc.
02-Jun-2020 RegeneRx Advisory on ARISE-3 Dry Eye Trial RegeneRx Biopharmaceuticals, Inc.
02-Jun-2020 BrainStorm Announces that Pivotal Phase 3 Trial Remains on Track for Topline Data in Q4-2020 Brainstorm Cell Therapeutics Inc
02-Jun-2020 Cellenkos(R) Inc. Announces FDA Clearance to Initiate Phase 1 Double- Blinded, Randomized, Placebo-Controlled Trial of Cryopreserved Cord Blood-Derived T-Regulatory Cells (CK0802) for Treatment of COVID-19 Associated Acute Respiratory Distress Syndrome Cellenkos, Inc.
02-Jun-2020 Surgeons and Spine Societies Increase Patient Access to Barricaid® for Discectomy Surgery Following Recent Coding Successes and Recognition in Updated Guidelines Intrinsic Therapeutics, Inc.
02-Jun-2020 Domainex announces the appointment of Dr. Eddy Littler as non-executive Chairman Domainex Ltd
02-Jun-2020 Oncoinvent Announces Dosing of First Patient with Radspherin® in Phase 1 Clinical Trial Oncoinvent AS
01-Jun-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
01-Jun-2020 Berkshire Sterile Manufacturing Secures $16.5 Million in Financing to Expand its Facility and Capabilities Berkshire Sterile Manufacturing
01-Jun-2020 Daiichi Sankyo and Syneos Health® Form Strategic Coalition for Development of Daiichi Sankyo’s ADC Oncology Pipeline Daiichi Sankyo, Inc.
01-Jun-2020 Sanofi announces closing of Regeneron stock sale Sanofi
01-Jun-2020 Sanifit Enhances Leadership Team with New Executive Appointments Sanifit
01-Jun-2020 Acacia Pharma Announces Debt for Equity Swap with Cosmo Pharmaceuticals Acacia Pharma Group plc
01-Jun-2020 ERYTECH Announces Poster Presentations at ASCO 2020 Annual Meeting ERYTECH Pharma
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting with the U.S. FDA Chi-Med
01-Jun-2020 Lynparza recommended for approval in EU by CHMP for BRCA-mutated metastatic pancreatic cancer AstraZeneca PLC